Abound Wealth Management Collegium Pharmaceutical, Inc Transaction History
Abound Wealth Management
- $271 Billion
- Q2 2024
A detailed history of Abound Wealth Management transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Abound Wealth Management holds 7 shares of COLL stock, worth $242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7
Previous 10
30.0%
Holding current value
$242
Previous $389,000
41.9%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
239Shares Held
39.7MCall Options Held
84.2KPut Options Held
18.6K-
Black Rock Inc. New York, NY5.79MShares$201 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$118 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$91.3 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$82.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$80.9 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.18B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...